LVOX yields 53.62% · PFE yields 6.13%● Live data
📍 LVOX pulled ahead of the other in Year 1
Combined, LVOX + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LVOX + PFE for your $10,000?
LiveVox, Inc. develops and provides cloud contact center software for businesses. Its products include Four Clouds, an outbound voice solution that enables to manage regulatory requirements with the option of three manual and one automated outbound dialing system; bundles, including two-way messaging, outbound campaigns and compliance, speech analytics, inbound contact center, and cloud interactive voice response (IVR) solutions; inbound voice solutions, which comprise automatic call distributor, IVR, and wallboards; and blended omnichannel solutions, such as voice, email, SMS, virtual agents, and webchat. The company also offers CRM, which leverages unified customer profiles to create, facilitate, and manages digital engagement; Workforce Optimization, that helps contact centers to measure and manage agent workforce; and SpeechIQ, an AI-driven speech analytics solution to promote compliance, productivity, and quality in contact centers. It serves financial services, teleservices, healthcare, telecom, customer care, BPO, and collection industries. The company has a strategic partnership with Telarus. LiveVox, Inc. was formerly known as Tools For Health, Inc. and changed its name to LiveVox, Inc. in June 2006. The company was incorporated in 1998 and is based in San Francisco, California. LiveVox, Inc. has additional locations in Atlanta, Georgia; Bengaluru, India; Denver, Colorado; Medellin, Colombia; New York, New York; St. Louis, Missouri; and Columbus, Ohio.
Full LVOX Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.